Feds slam the door on drug R&D use of chimps

The U.S. government has taken another big step forward in its campaign to end drug research projects involving chimps. Late in 2011 the NIH suspended grants for biomedical research using chimps. And the big agency followed up last year by retiring more than 100 chimps that had been used for R&D work. Now the Fish and Wildlife service is looking to list all chimps as an endangered species, dropping the controversial practice of designating wild chimps as endangered and captive chimps "threatened," a split classification that allowed the captives to be used in research work. Animal rights activists applauded the move, but you can be sure that chimp research will continue in a number of other countries around the world--for now. Story

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.